飛天雲動(06610.HK)預期中期淨利潤下降約45%
格隆匯8月23日丨飛天雲動(06610.HK)公吿,截至2024年6月30日止期間,集團預期將錄得(i)收入較截至2023年6月30日止期間減少約25%;及(ii)淨利潤較截至2023年6月30日止期間下降約45%。
期內收入及淨利潤的減少乃主要歸因於下列因素:(i)受宏觀經濟影響,整體互聯網廣吿客户投入預算減少,導致公司增強現實及虛擬現實(AR/VR)營銷服務業務收入下降,同時流量成本的提高亦造成該業務毛利率的下降;(ii)AR/VR內容業務儘管項目數量有所增加,但市場競爭激烈,導致項目單價及毛利率均有所下降;及(iii)AR/VR軟件即服務(SaaS)業務訂閲數量及定製化項目數量有所下降。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.